The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

This study is testing whether a supplement called Kinisoquin™ can reduce dangerous blood clots (thromboembolism) in people with advanced or locally advanced pancreatic cancer who are starting their first round of chemotherapy. **You may be eligible if...** - You are 18 or older - You have confirmed pancreatic cancer that has spread or is locally advanced - You are starting your first course of chemotherapy (or first chemotherapy after a recurrence) - You have a life expectancy of more than 4 months - Your blood counts and organ function are within acceptable limits **You may NOT be eligible if...** - You have already received chemotherapy for this diagnosis (unless it's a new recurrence) - You have very poor general health - Your blood clotting or organ function is severely impaired Talk to your doctor to see if this trial is right for you.